Chest
Original Research: COPDEconomic Benefits of Self-Management Education in COPD
Section snippets
Materials and Methods
The design and methods of this trial have been described in more detail elsewhere,12 and are briefly summarized below.
Study Subjects
The clinical results of our trial have been described elsewhere.12 Of the 469 eligible COPD patients, 251 refused to participate, while 27 agreed but could not be enrolled because they lived too far away from the study sites. The main reason for patient refusal was the perceived burden of study-related evaluations, given the 50% likelihood of remaining with usual care. Potential eligible patients who did not participate were similar to the 191 study participants with respect to sex, age, and
Discussion
This study has demonstrated that a multicomponent self-management education program with ongoing supervision by a case manager can reduce the use of health services among previously hospitalized patients with moderate-to-severe COPD. This reduction is primarily the result of fewer hospitalizations, emergency department visits, and unscheduled physician visits. Although the 1-year time frame may seem short to policy makers, we have recently shown that the benefit of our program is sustained past
Appendix
Participating members of the COPD axis of the Respiratory Health Network of the Fond de la Recherche en Santé du Québec were as follows: Jean Bourbeau, MD and Diane Nault, RN, Montréal Chest Institute of the Royal Victoria Hospital, McGill University Health Centre; Paolo Renzi, MD, Hôpital Notre-Dame, Centre hospitalier affilié de l’Université de Montréal; Marcel Julien, MD, Hôpital du Sacré-Cœur, Centre hospitalier affilié de l’Université de Montréal; Alain Beaupré, MD, Centre hospitalier
References (40)
The impact of COPD on lung health worldwide: epidemiology and incidence
Chest
(2000)Economic analysis of the Confronting COPD Survey: an overview of results
Respir Med
(2003)- et al.
Self-management and behaviour modification in COPD
Patient Educ Couns
(2004) - et al.
Economic analysis of respiratory rehabilitation
Chest
(1997) - et al.
Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness: the PASTMA Group
Lancet
(1992) - et al.
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD: a 1-year follow-up randomized, controlled trial
Respir Med
(2002) - et al.
Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease
Respir Med
(2000) - et al.
How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?
Respir Med
(2005) - et al.
If you build it, will they come? Reach and adoption associated with a comprehensive lifestyle management program for women with type 2 diabetes
Patient Educ Couns
(2002) - et al.
A systematic review of randomized trials of disease management programs in heart failure
Am J Med
(2001)
The effectiveness of disease and case management for people with diabetes: a systematic review
Am J Prev Med
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
Thorax
Characterization of the incidence and cost of COPD in the US [abstract]
Eur Respir J
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
Eur Respir J
Trends in COPD morbidity and mortality in the United States
Am Rev Respir Dis
Community diabetes care: a 10 year perspective
Diabetes Care
A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
N Engl J Med
Collaborative management of chronic illness
Ann Intern Med
Cited by (0)
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
†Members of the COPD axis of the Respiratory Health Network of the FRSQ who have participated in the research project are listed in the Appendix.
This study was made possible by an unrestricted grant from Boehringer Ingelheim Canada, Burlington, ON, in partnership with the Fonds de la recherche en santé du Québec, Montréal, QC, Canada. Dr. Schwartzman is the recipient of a Chercheur-Boursier Clinicien career award from the Fonds de la Recherche en Santé du Québec.